United States · Genetics startup
United States · C2i Genomics
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
Funding reportedLast round: Series B
What company datasets say C2i Genomics raised
Funding, as reported
Reported in all$112Min dollars
Rounds2
Last roundSeries B
Last round dateApr 2021
Investors listed12
Founders and team
From C2i Genomics's own website and the SEC filings it signed: 8 on the team.
- Marc StapleyChief Executive Officer
- Jonathan WygantChief Accounting Officer
- Rebecca ChambersChief Financial Officer
- Steven FrenchChief Information Officer
- Tracy WardChief Human Resources Officer
- Annie McGuireGeneral Counsel & Head of Market Access
- Asaf ZviranExecutive Officer, Directori
- Ezra SoferExecutive Officer, Directori
On the board, as filediAlex ParkerEli CasdinShaun Rodriguez
On a portfolio page
Investors who name them
Each firm lists C2i Genomics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Genetics in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put C2i Genomics in front of investors. Or tell us what we have wrong.